L
L. J. Davis
Researcher at Johns Hopkins University
Publications - 1
Citations - 1751
L. J. Davis is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Randomized controlled trial & Smoking cessation. The author has an hindex of 1, co-authored 1 publications receiving 1726 citations.
Papers
More filters
Journal ArticleDOI
Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1: The Lung Health Study
Nicholas R. Anthonisen,John E. Connett,James P. Kiley,Murray D. Altose,William C. Bailey,A. Sonia Buist,William A. Conway,Paul L. Enright,Richard E. Kanner,Peggy O'Hara,Gregory R. Owens,Paul D. Scanlon,Donald P. Tashkin,Robert A. Wise,M. D. Altose,Alfred F Connors,Susan Redline,C. Deitz,R. F. Rakos,W. A. Conway,A. Dehorn,J. C. Ward,C. S. Hoppe Ryan,R. L. Jentons,J. A. Reddick,C. Sawicki,R. A. Wise,S. Permutt,Cynthia S. Rand,P. D. Scanlon,L. J. Davis,R. D. Hurt,R. D. Miller,D. E. Williams,G. M. Caron,G. G. Lauger,S. M. Toogood,A. S. Buist,W. M. Bjornson,L. R. Johnson,W. C. Bailey,C. M. Brooks,J. J. Dolce,D. M. Higgins,M. A. Johnson,C. D. Lorish,B. A. Martin,D. P. Tashkin,A. H. Coulson,H. Gong,Philip Harber,V. C. Roth,M. Roth,Mitchell A. Nides,M. S. Simmons,I. Zuniga,N. R. Anthonisen,J. Manfreda,R. P. Murray,S. C. Rempel Rossum,J. M. Stoyko,J. E. Connett,M. O. Kjelsberg,M. K. Cowles,D. A. Durkin,P. L. Enright,K. J. Kurnow,W. W. Lee,P. G. Lindgren,S. J. Mongin,P. O'hara,H. T. Voelker,Lance A. Waller,G. R. Owens,R. M. Rogers,J. J. Johnston,F. P. Pope,F. M. Vitale,R. E. Kanner,M. A. Rigdon,K. C. Benton,P. M. Grant,M. Becklake,Benjamin Burrows,P. Cleary,P. Kimbel,L. Nett,J. K. Ockene,R. M. Senior,G. L. Snider,W. Spitzer,O. D. Williams,S. S. Hurd,J. P. Kiley,M. C. Ayres,S. M. Ayres,R. E. Hyatt,Benjamin A. Mason +97 more
TL;DR: An aggressive smoking intervention program significantly reduces the age-related decline in FEV 1 in middle-aged smokers with mild airways obstruction and use of an inhaled anticholinergic bronchodilator results in a relatively small improvement inFEV 1 that appears to be reversed after the drug is discontinued.